If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 1 Oct: Sustaining the UK’s malaria science leadership at Labour Party Conference
• 7 Oct: Malaria Science Index highlights the importance of investment and partnerships in malaria innovation
• 5 Oct: TB Alliance Announces Three Leadership Appointments
• 22 Jul: Last-resort antibiotics remain out of reach in Latin America and the Caribbean, review warns
• 3 Sep: New SARS-CoV-1 antibody available for vaccine researchers
• 9 Sep: PATH appoints Dr. Jeremy Farrar as Chief of Asia, Middle East, and Europe regional division
• 15 Oct: MMV and deepmirror recognized in TIME’s Best Inventions 2026
• 15 Sep: WHO Guidelines for malaria now include Coartem® Baby for newborns and young infants
• 6 Oct: Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
• 8 Oct: FIND Board appoints Dr Jutta Reinhard-Rupp as FIND’s Chief Executive Officer
• 3 Sep: IVI and Karolinska Institutet sign Memorandum of Understanding to strengthen existing cooperation in vaccine research and education
• 6 Sep: Prof. Umberto D'Alessandro joins EVI as Medical Director
MDGH
PDP Funder News/Announcements
• 2 Sep: Introducing the New Leader of Our Work on Global Health and Development Policy. Coefficient Giving
• 10 Sep: [Tanzania: Implementation study site report] Tackling Schistosomiasis in the STEPPS Project. GHIT
• 14 Sep: Wellcome CEO joins leaders warning the window for global health reform is closing. Wellcome
• 16 Sep: GHIT Fund Launches “NTDpedia” to Help Turn Apathy into Action Against Neglected Tropical Disease. GHIT
• 23 Sep: Unitaid marks 20 years and asks that global health reform be driven by equitable access. Unitaid
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 12 Oct: What is the future of product development?. Numerous PDPs
Other Reports/ Publications
• 21 Oct: Pipeline Report » 2026 Tuberculosis Vaccines. TAG
• 13 Mar: From Commitments to Action: Practical Pathways for Health Financing in Africa. Global Health Strategies
Related Press Releases/ Announcements/Articles
• 1 Oct: Commentary: Global health research makes America richer and healthier. University of Michigan Health
• 1 Oct: Sluggish donor response to CEPI’s pandemic prevention ask. Development Today
• 1 Oct: Can Africa make 60% of its vaccines by 2040? That’s a tall order, as the travails of South African companies show. Science
• 1 Oct: Symptom-agnostic endpoints in tuberculosis vaccine efficacy trials. The Lancet
• 1 Oct: Early lessons from lenacapavir PrEP roll-out in Zimbabwe. The Lancet HIV
• 2 Oct: Beyond diagnostic accuracy: defining the role of tongue swabs in decentralised tuberculosis screening. The Lancet
• 2 Oct: Addressing mosquito-borne disease trends as climate change bites. MedicalXpress
• 3 Sep: Closing the preparedness gap: moving beyond emergency response to sustain the medical countermeasure ecosystem. The Lancet
• 3 Sep: Ebola Outbreak ‘Still Evolving’ as Deaths Pass 3,000. Health Policy Watch
• 3 Sep: WHO grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel test to support Ebola outbreak response in the DRC. Financial Times
• 3 Oct: Inside the study for a remedy to fight Congo's deadliest Ebola outbreak. PBS
• 4 Sep: KI and IVI strengthen their collaboration in global health. Karolinska
• 4 Sep: Aspen opts not to make HIV prevention jab lenacapavir. Business Day
• 5 Oct: Opinion: Fostering affordable and equitable biomedical innovation. Business Line
• 6 Oct: Three Questions the Bundibugyo Ebola Outbreak Asks of CEPI’s 100 Days Mission. Geneva Health Files
• 6 Oct: Uganda launches Phase I clinical study of Bundibugyo virus disease vaccine. LSHTM
• 8 Sep: Global health reform is missing a generation. The Lancet
• 7 Oct: H.I.V. Research Networks Face Uncertain Future Amid Funding Delays. The New York Times
• 8 Sep: Meet 4 people who got the HIV prevention jab. Bhekisisa
• 8 Oct: How a new long-acting HIV drug combo tackles resistance. MedicalXpress
• 8 Oct: Why is dengue spreading while malaria has declined?. News Medical
• 8 Oct: NIH revives network to study emerging diseases—but its new restrictions baffle scientists. Science
• 9 Sep: Gavi’s vaccine transition was never about RFK's fixation on mercury. Devex
• 9 Oct: Germany Hosts the World Health Summit, But Has No Plan for the World’s Health. Health Policy Watch
• 9 Oct: Is the global health architecture reform progressing?. Global Public Health Insights
• 10 Oct: Beyond the Breakthrough: Why New HIV Prevention Needs a Delivery Revolution for Girls. SHRM
• 10 Oct: 50 years of Ebola research and response. The Lancet
• 10 Sep: Nigeria achieves historic milestone as Health Textiles Nigeria begins manufacture of Vestergaard’s PermaNet® Dual mosquito nets. Vestergaard
• 11 Sep: Senegal launches pilot study on schistosomiasis treatment for preschool-aged children in Kédougou region. UNDP
• 12 Oct: Final preparations underway for pivotal Phase 2/3 Bundibugyo vaccine trial. CEPI
• 12 Oct: Why scientific breakthroughs won't end HIV if communities are left behind. The Advocate
• 12 Oct: Exclusive: Global Fund eyes new funding mechanism for malaria. Devex
• 13 Oct: With Only Three ‘No’ Votes, UN Adopts Political Declaration on Pandemic Preparedness. Health Policy Watch
• 13 Oct: Mosquito-based malaria control through genetic, microbial and immunological innovations. Nature
• 14 Oct: Innovative roadmaps for sustainable antimicrobial resistance interventions. Science
• 14 Oct: Mosquito saliva study opens new doors for blocking Zika, dengue, and West Nile infections. News Medical
• 14 Oct: Ebola vaccine triggers cross reactive T cells against Bundibugyo ebolavirus. News Medical
• 15 Oct: HIV finds escape routes from a preventive antibody—but newer antibodies may close them. MedicalXpress
• 15 Oct: Good gut bacteria vs bad: what we learnt about antibiotic resistance from a community in Nairobi. The Conversation
• 15 Oct: Medicines for Malaria Venture and Deepmirror dd4gh. Time Magazine
• 15 Oct: Public and private funders inject €159 million in global health research. Science Business
• 15 Oct: Cross-neutralisation of authentic Ebola virus and Bundibugyo virus following natural infection or Ervebo vaccination. The Lancet
• 16 Oct: Continuity Biosciences Secures $9.6M Gates Foundation Grant to Advance Multi-Year HIV Prevention Implant. BioPharma
• 16 Sep: Pragmatic tuberculosis trials must measure what determines implementation.The Lancet
• 16 Sep: Gilead accelerates global access planning for investigational once-yearly lenacapavir for HIV prevention. Gilead
• 16 Oct: CEPI and World Bank Group partner to strengthen sustainable vaccine manufacturing in ASEAN. CEPI
• 16 Oct: World Health $ummit: The Necessary Evil of Capitalist Global Health?. IHP
• 16 Oct: First participants vaccinated with Oxford's CEPI-backed Lassa shot in Ghana. CEPI
• 17 Sep: Can we reform the global health system?. Alliance for Health Policy & Systems Research
• 17 Sep: Global health agrees on reform. Now, who will give up power?. Devex
• 17 Sep: Building sustainable diagnostic ecosystems for global health. Nature
• 18 Sep: Global health reform and last-mile integration: the missing link in pandemic preparedness. Gavi
• 18 Sep: New TB vaccines could avert millions of deaths, LSHTM modelling suggests. LSHTM
• 18 Oct: Ebola vaccine trials 'reason for hope' in DR Congo and beyond. RFI
• 18 Sep: Institute of Philanthropy Commits Nearly US$5 Million to Bring Innovative TB Diagnostics Closer to Patients. The Global Fund
• 18 Sep: US Medicare Pricing Policies Could Drive Global Costs and Hinder Access Worldwide. Health Policy Watch
• 18 Sep: PAHO, Gilead deal expands lenacapavir access for 14 countries. Devex
• 18 Sep: Coefficient Giving launches $165M fund to help countries navigate aid cuts. Devex
• 18 Sep: Member States advance negotiations on pathogen access and benefit-sharing ahead of UN General Assembly meeting on pandemics. WHO
• 18 Sep: Who is really shaping global health reform?. PLOS
• 19 Oct: How WHO's pandemic hub plans to identify all new threats within 24 hours. Devex
• 20 Sep: Ethiopia, Norway and UK commit US$240 million to CEPI’s global plan to tackle epidemic and pandemic threats. CEPI
• 21 Sep: Ervebo vaccine trial kicks off in Ebola-ravaged DR Congo. CIDRAP
• 21 Sep: Pandemic Agreement Negotiator Warns Against Losing Momentum. Health Policy Watch
• 21 Oct: Now What with Injectable LEN for PrEP? How to Translate Ambition into Accelerated Delivery and Impact. AVAC
• 21 Oct: Sevuparin in children with severe malaria: a phase I safety and dose-finding trial. Nature
• 21 Sep: Gilead to extend access to lenacapavir and broaden its voluntary licences to include a new once-yearly formulation. Access to Medicines Foundation
• 21 Sep: New WHO report calls for stronger ethics oversight of AI-related health research. WHO
• 21 Sep: Ebola vaccine trial begins in DR Congo. UN News
• 21 Sep: ViiV Healthcare makes new £9.75 million investment to accelerate HIV response for paediatric and adolescent population. ViiV
• 22 Sep: Accra Reset’s Plan for Health Sovereignty Includes Closing Some Global Health Bodies. Health Policy Watch
• 22 Sep: The Accra Reset’s 10 commandments. Devex
• 22 Sep: A 30-day benznidazole regimen offers safer Chagas disease treatment option. NewsMedical
• 22 Sep: France releases infertile Asian tiger mosquitoes to fight dengue threat. The Telegraph
• 23 Sep: Wellcome CEO calls for rethink of global health institutions’ mandates. Devex
• 23 Sep: ‘Almost unprecedented’ cuts in malaria funding will hurt UK pandemic planning, leading scientists say. The Independent
• 23 Sep: White House Backtracks on Plan to Exert New Control Over N.I.H. Grants. The New York Times
• 24 Sep: Global Fund Prepares for Major Expansion in Access to Lenacapavir as Generic Supply Approaches. The Global Fund
• 24 Sep: Malaria parasite can reawaken after years: New vaccine target may block liver infection. MedicalXpress
• 24 Sep: Fractured ecosystems, climate change raise risk of zoonotic, vector-borne disease outbreaks, study finds. CIDRAP
• 24 Sep: Diagnostic performance and testing costs of pooled testing for molecular detection of tuberculosis in seven countries: a prospective, observational, diagnostic accuracy study. The Lancet
• 25 Sep: What the NIH cuts really mean for global health. Impact for Global Health
• 25 Sep: Targeted HIV drug resistance testing moves into routine care in South Africa. MedicalXpress
• 25 Sep: UN Declaration on Pandemic Readiness Appears Headed for General Assembly Approval. Health Policy Watch
• 25 Sep: There's a global pandemic treaty that's signed — and in 'limbo.' What's the holdup?. NPR
• 25 Sep: World leaders renew commitment to protect the world from future pandemics. WHO
• 25 Sep: New tool to mutate phages boosts the fight against superbugs. NewsMedical
• 25 Sep: U.S. Rejects U.N. Declaration on Preparing for Future Pandemics. The New York Times
• 26 Sep: Platform trials: the study design transforming infectious diseases. The Lancet
• 26 Sep: The Accra Reset must turn sovereignty into country power. The Lancet
• 30 Sep: Tuberculosis treatment has advanced — now we need to stop drug resistance dragging us backwards. Nature
• 28 Sep: Following the Best Science Does Not Always Make the Best Vaccine Investment. CGD
• 28 Sep: From the first vaccines against malaria to the first WHO-approved primary clinical trials registry in Africa: the AU-EU R&I Cooperation delivering in Public Health. Delegation of the EU to African Union
• 28 Sep: Financial Boost for Global Health on Sidelines of UN General Assembly. Health Policy Watch
• 29 Sep: UK rabies vaccine trial could also unlock protection against Disease X. CEPI
• 30 Sep: Made in Africa: New measles rapid diagnostic tests mark breakthrough for vaccination efforts. Gavi
• 30 Sep: How to spend $25 billion on science: OpenAI’s staggeringly rich research charity gets under way. Nature
• 30 Sep: Tuberculosis treatment has advanced — now we need to stop drug resistance dragging us backwards. Nature
Upcoming Meetings/ Webinars
--------------------------